The good and bad side of anti-cancer compounds

Courtesy EurekAlert! - Cancer  Wed, 04/09/2008 - 23:00

Two recent studies by researchers at the Vanderbilt-Ingram Cancer Center provide a potential mechanism by which investigational anti-cancer compounds known as HDAC inhibitors specifically damage cancer cells as well as clues about possible adverse effects of these compounds -- findings with important implications for their clinical use as cancer therapies.

Tags:

 

More related items

Prostate cancer drug reduces testosterone levels in...
(Wiley-Blackwell) Men who took degarelix for prostate cancer saw their testosterone and PSA levels drop in as little as three days. An important feature of the drug is that it does not cause...

IDO2 an active enzyme to target in pancreatic cancer
(Thomas Jefferson University) An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy.

Breast cancer in men: Mammography and sonography...
(American Roentgen Ray Society) Mammography and sonography findings help doctors identify and appropriately treat breast cancer in men, according to a study performed at the University of...

Weil Nutritional Daily Multivitamin for Optimum...

AmLactin Moisturizing Body Lotion, 14.1-Ounces


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com